Baseline (n = 31) | 1 Year (n = 27) | |
---|---|---|
Beta-blocker | 31 (100%) | 27 (100%) |
ACE-Inhibior/AT 1 -Antagonist | 29 (94%) | 26 (96%) |
Ca ++ -Antagonist | 26 (84%) | 24 (89%) |
CSE-inhibitor | 31 (100%) | 27 (100%) |
Long-acting nitrate | 31 (100%) | 25 (93%) |
Morphine derivate | 12 (39%) | 1 (4%) |